Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years.

Nicolette VeracruzRobert G Gish Ramsey C CheungAmit S ChitnisRobert J Wong

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

Decreases in HBV and HCV DALYs from 2010 to 2019 were observed. Disparities in DALY improvements across world regions suggest unequal access to viral hepatitis care and treatment. Achieving goals of viral hepatitis elimination will require enhanced prevention efforts and funding for high-burden regions and regions that have not had substantial reductions in DALYs because of HBV and HCV.

Keyphrases

hepatitis b virus
hepatitis c virus
sars cov
quality improvement
liver failure
healthcare
human immunodeficiency virus
palliative care
multiple sclerosis
risk factors
pain management
combination therapy
chronic pain
global health
health insurance
replacement therapy